Nefopam
Based on 3 publication(s) in Google Scholar
Nefopam (Fenazoxine) is an orally active, non-opioid and non-steroidal centrally acting analgesic agent. Nefopam blocks voltage-sensitive sodium channels (IC50=27 μM) and modulates glutamatergic transmission in rodents. Nefopam can be used in studies of neuropathic pain, anticonvulsant, as well as the prevention of postoperative shivering and hiccups.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 13669-70-0
- 分子式: C17H19NO
- 分子量:253.34
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
MedChemExpress（MCE）の使用を引用している文献 Nefopam
More
生物活性
Nefopam (0.1-100 μM; 15 min) inhibits the uptake of 22Na in a concentration-dependent manner in SK-N-SH cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SK-N-SH cells
-
Concentration:0.1-100 µM
-
Incubation Time:15 min (preincubate)
-
Result:Inhibited the uptake of 22Na with an IC50 value of 27 µM.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Adult male NMRI mice (25-30 g; 6 to7-week-old; electroshock-induced seizures model)[1]
-
Dosage:0-10 mg/kg
-
Administration:Intravenous injection; single
-
Result:Produced dose-dependent protection against maximal electroshock seizures in mice with an ED50 of 3.8 (2.9-5.1) mg/kg.
-
Animal Model:Adult male mice (10-week-old; 25-30 g; vincristine-induced peripheral neuropathy model)[2].
-
Dosage:10, 30, 60 mg/kg
-
Administration:Intraperitoneal injection; single
-
Result:Significantly decreased the percentage of NK1 receptors in the spinal cord at dosage of 60 mg/kg.
Showed a sustained increase in paw withdrawal threshold against mechanical stimuli.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
化学情報
-
CAS 番号 13669-70-0
-
分子量 253.34
-
分子式 C17H19NO
-
SMILES
CN1CCOC(C2=CC=CC=C2)C3=CC=CC=C3C1
-
別名
Fenazoxine
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
ACS Omega
2020 Oct 12;5(41):26551-26561. PMID: 33110983 -
Sci Rep
2019 Jun 21;9(1):9005. PMID: 31227757 -
Mol Carcinog
KDM6A Exhibits Antitumor Activities Toward Ovarian Cancer by Epigenetically Activating Transcription of ISG-15. [Abstract]2025 Nov 18. PMID: 41252674
純度とドキュメンテーション
参考文献
[1]. Verleye M, et al. Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents. Brain Res. 2004 Jul 9;1013(2):249-55. [Content Brief]
[2]. Lee JY, et al. The Antiallodynic Effect of Nefopam on Vincristine-Induced Neuropathy in Mice. J Pain Res. 2020 Feb 7;13:323-329. [Content Brief]
[3]. Kim KH, et al. Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain. 2014 Apr;27(2):103-11. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Nefopam 関連分類
HY-133195 関連分類
Powered by Bioz